| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 93.364 | 115.499 | 101.301 | 101.424 | 100.843 | 101.228 | 211.384 | 188.543 | 216.861 | 312.672 |
| Total Income - EUR | 93.366 | 115.499 | 101.301 | 101.424 | 100.843 | 101.228 | 214.655 | 193.612 | 216.861 | 312.672 |
| Total Expenses - EUR | 50.823 | 50.135 | 54.262 | 44.931 | 46.825 | 36.132 | 142.170 | 103.910 | 169.892 | 166.718 |
| Gross Profit/Loss - EUR | 42.543 | 65.364 | 47.039 | 56.493 | 54.018 | 65.096 | 72.485 | 89.703 | 46.969 | 145.954 |
| Net Profit/Loss - EUR | 36.675 | 61.209 | 44.880 | 55.479 | 53.015 | 64.166 | 70.373 | 87.395 | 45.986 | 137.237 |
| Employees | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 2 | 0 | 0 |
Check the financial reports for the company - Medsor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.068 | 93.990 | 100.844 | 1.602 | 65.693 | 59.617 | 64.792 | 8.305 | 120.068 | 84.308 |
| Current Assets | 121.770 | 59.601 | 9.186 | 292.229 | 285.694 | 24.955 | 19.766 | 161.087 | 88.994 | 231.672 |
| Inventories | 0 | 0 | 3.309 | 3.407 | 0 | 0 | 0 | 1.066 | 0 | 2.081 |
| Receivables | 121.337 | 0 | 2.301 | 281.823 | 284.246 | 0 | 14.813 | 142.617 | 88.689 | 233.107 |
| Cash | 433 | 59.601 | 3.576 | 6.998 | 1.448 | 24.955 | 4.953 | 17.404 | 305 | -3.516 |
| Shareholders Funds | 105.397 | 98.412 | 105.061 | 289.238 | 336.651 | 84.572 | 83.062 | 155.293 | 201.785 | 302.899 |
| Social Capital | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | 41.441 | 55.179 | 4.969 | 4.593 | 14.736 | 0 | 1.496 | 14.098 | 7.276 | 13.082 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medsor S.r.l.